Anti D 150mcg Inj,Budesonide 200 mcg Inhaler 240 metered doses,Inj docarvim and Miromavimab 1500IU
Other · open
Key facts
- Closing date: 17 Aug 2026
- Status: open
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: No
Commercial terms
- Make in India (MII): No
- MSE preference: No
1 tender document(s) available — sign up to download.